Stock Analysts

Integral Technologies (ITKG) Advancing Towards Commercial Launch

Integral Technologies, Inc. (OTC: ITKG ) By Marla Backer Integral’s growing financial and operating momentum is illustrated, we believe, by ramping revenue, a strengthening balance sheet, new commercial agreements and the company’s steps to uplist ITKG shares to the Nasdaq. Fiscal 2013 results underscore the strides the company has made to monetize ElectriPlast, in our view, and subsequent announcements reflect continued advancements towards this goal […]

Peter Schiff

The Scary Truth Behind the Halloween Rally

[youtube 0wp6lUUnkJw] The Schiff Report Video Blog SIGN UP FOR MY FREE NEWSLETTER: http://www.europac.net/subscribe_free_reports AMERICA’S TAX-FREE ZONE: http://www.internationalman.com/go/uas8c-2/EPC Buy my newest book at http://www.tinyurl.com/RealCrash Friend me on http://www.Facebook.com/PeterSchiff Follow me on http://www.Twitter.com/PeterSchiff […]

Stock Analysts

Can Michael Kors (KORS) Keep the Earnings Streak Alive?

We expect Michael Kors Holdings Limited ( KORS ), the designer, marketer and retailer of branded women’s apparel and accessories, and men’s apparel, to beat expectations when it reports second-quarter fiscal 2015 results on Nov 4. In the last quarter, it had delivered a positive earnings surprise of 12.4%. Let’s see how things are shaping up for this announcement. […]

Stock Analysts

Will Low Crude Price Drive Valero (VLO) Q3 Earnings Beat?

Leading North American independent refiner and marketer of petroleum products, Valero Energy Corporation ( VLO ) is set to report third-quarter 2014 results on Nov 4. Let’s see how things are shaping up prior to the announcement. In the last quarter, the company’s earnings of $1.22 per share beat the Zacks Consensus Estimate of $1.19 […]

Stock Analysts

Bristol-Myers Squibb Up on Positive Opdivo Phase II Study

Bristol-Myers Squibb Company ( BMY ) gained 8.9% after the company announced encouraging data from the phase II CheckMate – 063 study on immuno-oncology drug Opdivo (nivolumab, a PD-1 immune checkpoint inhibitor). Data from the study will be presented during the Plenary Session at the 2014 Chicago Multidisciplinary Symposium on Thoracic Oncology. The single-arm, open-label CheckMate – 063 study evaluated the use of Opdivo as monotherapy in patients suffering from advanced squamous cell non-small cell lung cancer (NSCLC) who have progressed after at least two prior systemic treatments. […]

Stock Analysts

Will Marathon Oil (MRO) Earnings Miss on Lower Realization?

Marathon Oil Corporation ( MRO ), the oil and natural gas exploration and production (E&P) firm, is set to release third-quarter 2014 financial results on Monday, Nov 3, after the close of the trading session. The company’s earnings history is a mixed bag. Marathon Oil has beaten the Zacks Consensus Estimate in two of the trailing four quarters while missing the same in the other two. […]

Stock Analysts

Vanguard Natural (VNR): Rebounding This Earnings Season?

We expect Vanguard Natural Resources LLC ( VNR ) to beat expectations when it reports third-quarter 2014results on Nov 3, after the closing bell. Last quarter, the upstream energy player delivered a negative earnings surprise of 22.86%. We note that Vanguard Natural Resources has underperformed the Zacks Consensus Estimate in the preceding four quarters with an average miss of 27.58% […]

Stock Analysts

Enterprise Products Q3 Earnings In Line on Record Volumes

Enterprise Products Partners LP ( EPD ) reported third-quarter 2014 adjusted earnings per limited partner unit of 37 cents, in line with the Zacks Consensus Estimate. The bottom line improved from the year-ago adjusted quarterly earnings of 32 cents. Record levels of natural gas liquid (NGL), crude oil, refined products and petrochemical pipeline volumes during the quarter, a higher NGL fractionation volume and improved fee-based natural gas processing volume primarily led to the improvement […]

Stock Analysts

Western Union Q3 Earnings Beat Estimates, Ups ’14 EPS

The Western Union Company ( WU ) reported third-quarter 2014 operating earnings per share (EPS) of 44 cents per share, which were ahead of the Zacks Consensus Estimate of 39 cents. Earnings were also up 13% on a year-over-year basis. Western Union’s better-than-expected EPS were driven by revenue growth across all its segments, along with tight expense management […]